Cohn R H, Cassiman J J, Bernfield M R
J Cell Biol. 1976 Oct;71(1):280-94. doi: 10.1083/jcb.71.1.280.
Mouse 3T3 cells and their Simian Virus 40-transformed derivatives (3T3SV) were used to assess the relationship of transfromation, cell density, and growth control to the cellular distribution of newly synthesized glycosaminoglycan (GAG). Glucosamine- and galactosamine-containing GAG were labeled equivalently by [3H=A1-glucose regardless of culture type, allowing incorporation into the various GAG to be compared under all conditions studied. Three components of each culture type were examined: the cells, which contain the bulk of newly synthesized GAG and are enriched in chondroitin sulfate and heparan sulfate; cell surface materials released by trypsin, which contain predominantly hyaluronic acid; and the media , which contain predominantly hyaluronic acid and undersulfated chondroitin sulfate. Increased cell density and viral transformation reduce incorporation into GAG relative to the incorporation into other polysaccharides. Transformation, however, does not substantially alter the type or distribution of newly synthesized GAG; the relative amounts and cellular distributions were very similar in 3T3 and 3T3SV cultures growing at similar rates at low densities. On the other hand, increased cell density as well as density-dependent growth inhibition modified the type and distribution of newly synthesized GAG. At high cell densities both cell types showed reduced incorporation into hyaluronate and an increase in cellular GAG due to enhanced labeling of chondroitin sulfate and heparan sulfate. These changes were more marked in confluent 3T3 cultures which also differed in showing substantially more GAG label in the medium and in chondroitin-6-sulfate and heparan sulfate at the cell surface. Since cell density and possibly density-dependent inhibition of growth but not viral transformation are major factors controlling the cellular distribution and type of newly synthesized GAG, differences due to GAG's in the culture behavior of normal and transformed cells may occur only at high cell density. The density-induced GAG alterations most likely involved are increased condroitin-6-sulfate and heparan sulfate and decreased hyaluronic acid at the cell surface.
小鼠3T3细胞及其猿猴病毒40转化衍生物(3T3SV)被用于评估转化、细胞密度和生长控制与新合成糖胺聚糖(GAG)细胞分布之间的关系。无论培养类型如何,含葡萄糖胺和半乳糖胺的GAG都能被[3H] - D - 葡萄糖等效标记,从而能够在所有研究条件下比较其掺入各种GAG的情况。对每种培养类型的三个组分进行了检测:细胞,其含有大部分新合成的GAG,并富含硫酸软骨素和硫酸乙酰肝素;胰蛋白酶释放的细胞表面物质,其主要含有透明质酸;以及培养基,其主要含有透明质酸和硫酸化不足的硫酸软骨素。相对于掺入其他多糖,细胞密度增加和病毒转化会降低GAG的掺入。然而,转化并不会显著改变新合成GAG的类型或分布;在低密度下以相似速率生长的3T3和3T3SV培养物中,其相对含量和细胞分布非常相似。另一方面,细胞密度增加以及密度依赖性生长抑制改变了新合成GAG的类型和分布。在高细胞密度下,两种细胞类型都显示出透明质酸盐掺入减少,并且由于硫酸软骨素和硫酸乙酰肝素标记增强,细胞内GAG增加。这些变化在汇合的3T3培养物中更为明显,其在培养基以及细胞表面的硫酸软骨素 - 6 - 硫酸酯和硫酸乙酰肝素中也显示出更多的GAG标记。由于细胞密度以及可能的密度依赖性生长抑制而非病毒转化是控制新合成GAG细胞分布和类型的主要因素,正常细胞和转化细胞培养行为中因GAG导致的差异可能仅在高细胞密度时出现。密度诱导的GAG改变最可能涉及细胞表面硫酸软骨素 - 6 - 硫酸酯和硫酸乙酰肝素增加以及透明质酸减少。